Since folks who have the APOE e4 gene variant appear to have a larger chance of significant troubles, the FDA endorses becoming tested to the gene variant before starting treatment with lecanemab or donanemab. Mild cognitive impairment is important to acknowledge because it boosts an individual’s hazard of producing dementia https://aldousd186alv6.plpwiki.com/user